Shane Arsenault

The development of clinically useful biomarkers in MS 2:59
The development of clinically useful biomarkers in MS
Shane Arsenault • 20 Feb 2023
Blood biomarkers of disease activity in MS 3:32
Blood biomarkers of disease activity in MS
Shane Arsenault • 20 Feb 2023
CSF immune cell phenotyping & NfL to measure inflammatory activity and DMT response in MS 5:27
CSF immune cell phenotyping & NfL to measure inflammatory activity and DMT response in MS
Shane Arsenault • 20 Feb 2023
Review of BTK inhibition in MS 3:41
Review of BTK inhibition in MS
Shane Arsenault • 20 Feb 2023
The content of VJNeurology is intended for healthcare professionals